Market Overview:
The global opioid drugs market is expected to grow at a CAGR of 3.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing prevalence of chronic pain, rising demand for pain relief medications, and growing awareness about opioids among healthcare professionals and patients. Based on type, the global opioid drugs market is segmented into buprenorphine, fentanyl, hydrocodone, morphine, oxycodone, tramadol and others. The buprenorphine segment is expected to account for the largest share of the global opioid drugs market in 2018. This segment is projected to grow at a CAGR of 4% during the forecast period from 2018 to 2030. Buprenorphine is an effective analgesic that has a low potential for abuse and dependence compared with other opioids such as morphine or oxycodone. It also has fewer side effects than other opioids and hence finds widespread use in various applications such as anesthesia, pain relief etc., thereby driving its growth in this market. Based on application, the global opioid drugs market is divided into anesthesia (including general anesthesia), pain relief (including acute & chronic), cough suppression (including antitussive agents), diarrhea suppression (including antidiarrheal agents) de-addiction therapy (opioid detoxification) & others).
Product Definition:
Opioid drugs are a class of pain medications that include morphine, codeine, oxycodone and fentanyl. They work by reducing the intensity of pain signals reaching the brain.
Buprenorphine:
Buprenorphine is a drug used to treat pain and as an opioid substitute in patients who are physically dependent on opioids. Opioid drugs include both legal prescription medications such as codeine, morphine, and oxycodone as well as illegal street drugs such as heroin and fentanyl. The growing rate of accidental poisoning deaths from opioids has raised alarms for public health authorities across the globe.
Fentanyl:
Fentanyl is an opioid drug, which is commonly prescribed for pain management. It’s a strong pain-relieving medicine that may be used as anesthetic for surgical procedures. The drug was first developed in the 1960s by the German pharmaceutical company Bayer and has been widely available since then under various brand names such as Actavis, WEX, and Tylenol 3 among others.
Application Insights:
Based on the application, the global market is segmented into pain relief, anesthesia, diarrhea suppression, cough suppression and deaddiction. The pain relief segment dominated the overall market in terms of revenue in 2017. Anesthesia was estimated as the second-largest segment due to high product usage for surgical procedures. However, due to rising awareness about adverse effects associated with opioid drugs such as respiratory depression and coma during non-intravenous administration among healthcare professionals an increasing number of patients are opting for alternative treatment options leading to a decline in demand for opioids across various applications.
Regional Analysis:
North America dominated the global market in 2017, owing to the presence of a large number of opioid-based prescription drugs. The region is expected to maintain its dominance over the forecast period due to factors such as increasing prevalence of chronic pain and diarrhea, rising awareness about these products and high disposable income. In addition, government initiatives for controlling drug abuse are also expected to drive growth during this period. For instance, in October 2016 ‘Prescription Drug Monitoring’ was added as an addendum for Prescriber Universal Identification Number (PUI) under Medicare Part B.
However, Asia Pacific is anticipated to be the fastest growing region with a CAGR exceeding 6% from 2018 to 2030 owing their huge population base suffering from chronic diseases such as diabetes and arthritis that require long term treatment with opioids.
Growth Factors:
- Increasing prevalence of chronic pain: The global prevalence of chronic pain is estimated to be around 20%. This number is expected to grow as the population ages. Opioid drugs are effective in managing chronic pain and are thus likely to see increasing demand in the coming years.
- Rising awareness about opioid drugs: There has been a growing awareness about the benefits of opioid drugs in recent years, especially for the treatment of chronic pain. This is likely to lead to an increase in demand for these drugs in the future.
- Growing use of opioids for non-pain indications: Opioid drugs are increasingly being used for non-pain indications such as cough suppression and diarrhea relief. This is due to their favorable safety profile and efficacy profile compared with other classes of medications available for these indications.
- Launch of new products: Several new products have been launched in the opioid drug market over the past few years, including abuse-deterrent formulations (ADFs) and long-acting opioids (LAOs). These new products are likely to boost growth prospects for this market over the next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Opioid Drugs Market Research Report
By Type
Buprenorphine, Fentanyl, Hydrocodone, Morphine, Oxycodone, Tramadol, Others, Opioid Drug
By Application
Anesthesia, Pain relief, Cough suppression, Diarrhea suppression, Deaddiction, Others
By Companies
Acura Pharmaceuticals, Cipher Pharmaceutical Inc., Daiichi Sankyo, Johnson?Johnson, Lupin Limited, Pfizer, Sun Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Opioid Drug
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Opioid Drugs Market Report Segments:
The global Opioid Drugs market is segmented on the basis of:
Types
Buprenorphine, Fentanyl, Hydrocodone, Morphine, Oxycodone, Tramadol, Others, Opioid Drug
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Anesthesia, Pain relief, Cough suppression, Diarrhea suppression, Deaddiction, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Acura Pharmaceuticals
- Cipher Pharmaceutical Inc.
- Daiichi Sankyo
- Johnson?Johnson
- Lupin Limited
- Pfizer
- Sun Pharmaceuticals
- Teva Pharmaceutical Industries Ltd.
- Opioid Drug
Highlights of The Opioid Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Buprenorphine
- Fentanyl
- Hydrocodone
- Morphine
- Oxycodone
- Tramadol
- Others
- Opioid Drug
- By Application:
- Anesthesia
- Pain relief
- Cough suppression
- Diarrhea suppression
- Deaddiction
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Opioid Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Opioid drugs are medications that are derived from opium and include morphine, codeine, fentanyl, and oxycodone. They work by binding to opioid receptors in the brain to produce pain relief and other effects. Opioid drugs can be addictive and cause serious side effects if used incorrectly or for too long.
Some of the major players in the opioid drugs market are Acura Pharmaceuticals, Cipher Pharmaceutical Inc., Daiichi Sankyo, Johnson?Johnson, Lupin Limited, Pfizer, Sun Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Opioid Drug.
The opioid drugs market is expected to grow at a compound annual growth rate of 3.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Opioid Drugs Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Opioid Drugs Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Opioid Drugs Market - Supply Chain
4.5. Global Opioid Drugs Market Forecast
4.5.1. Opioid Drugs Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Opioid Drugs Market Size (000 Units) and Y-o-Y Growth
4.5.3. Opioid Drugs Market Absolute $ Opportunity
5. Global Opioid Drugs Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Opioid Drugs Market Size and Volume Forecast by Type
5.3.1. Buprenorphine
5.3.2. Fentanyl
5.3.3. Hydrocodone
5.3.4. Morphine
5.3.5. Oxycodone
5.3.6. Tramadol
5.3.7. Others
5.3.8. Opioid Drug
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Opioid Drugs Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Opioid Drugs Market Size and Volume Forecast by Application
6.3.1. Anesthesia
6.3.2. Pain relief
6.3.3. Cough suppression
6.3.4. Diarrhea suppression
6.3.5. Deaddiction
6.3.6. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Opioid Drugs Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Opioid Drugs Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Opioid Drugs Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Opioid Drugs Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Opioid Drugs Demand Share Forecast, 2019-2026
9. North America Opioid Drugs Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Opioid Drugs Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Opioid Drugs Market Size and Volume Forecast by Application
9.4.1. Anesthesia
9.4.2. Pain relief
9.4.3. Cough suppression
9.4.4. Diarrhea suppression
9.4.5. Deaddiction
9.4.6. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Opioid Drugs Market Size and Volume Forecast by Type
9.7.1. Buprenorphine
9.7.2. Fentanyl
9.7.3. Hydrocodone
9.7.4. Morphine
9.7.5. Oxycodone
9.7.6. Tramadol
9.7.7. Others
9.7.8. Opioid Drug
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Opioid Drugs Demand Share Forecast, 2019-2026
10. Latin America Opioid Drugs Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Opioid Drugs Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Opioid Drugs Market Size and Volume Forecast by Application
10.4.1. Anesthesia
10.4.2. Pain relief
10.4.3. Cough suppression
10.4.4. Diarrhea suppression
10.4.5. Deaddiction
10.4.6. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Opioid Drugs Market Size and Volume Forecast by Type
10.7.1. Buprenorphine
10.7.2. Fentanyl
10.7.3. Hydrocodone
10.7.4. Morphine
10.7.5. Oxycodone
10.7.6. Tramadol
10.7.7. Others
10.7.8. Opioid Drug
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Opioid Drugs Demand Share Forecast, 2019-2026
11. Europe Opioid Drugs Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Opioid Drugs Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Opioid Drugs Market Size and Volume Forecast by Application
11.4.1. Anesthesia
11.4.2. Pain relief
11.4.3. Cough suppression
11.4.4. Diarrhea suppression
11.4.5. Deaddiction
11.4.6. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Opioid Drugs Market Size and Volume Forecast by Type
11.7.1. Buprenorphine
11.7.2. Fentanyl
11.7.3. Hydrocodone
11.7.4. Morphine
11.7.5. Oxycodone
11.7.6. Tramadol
11.7.7. Others
11.7.8. Opioid Drug
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Opioid Drugs Demand Share, 2019-2026
12. Asia Pacific Opioid Drugs Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Opioid Drugs Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Opioid Drugs Market Size and Volume Forecast by Application
12.4.1. Anesthesia
12.4.2. Pain relief
12.4.3. Cough suppression
12.4.4. Diarrhea suppression
12.4.5. Deaddiction
12.4.6. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Opioid Drugs Market Size and Volume Forecast by Type
12.7.1. Buprenorphine
12.7.2. Fentanyl
12.7.3. Hydrocodone
12.7.4. Morphine
12.7.5. Oxycodone
12.7.6. Tramadol
12.7.7. Others
12.7.8. Opioid Drug
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Opioid Drugs Demand Share, 2019-2026
13. Middle East & Africa Opioid Drugs Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Opioid Drugs Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Opioid Drugs Market Size and Volume Forecast by Application
13.4.1. Anesthesia
13.4.2. Pain relief
13.4.3. Cough suppression
13.4.4. Diarrhea suppression
13.4.5. Deaddiction
13.4.6. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Opioid Drugs Market Size and Volume Forecast by Type
13.7.1. Buprenorphine
13.7.2. Fentanyl
13.7.3. Hydrocodone
13.7.4. Morphine
13.7.5. Oxycodone
13.7.6. Tramadol
13.7.7. Others
13.7.8. Opioid Drug
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Opioid Drugs Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Opioid Drugs Market: Market Share Analysis
14.2. Opioid Drugs Distributors and Customers
14.3. Opioid Drugs Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Acura Pharmaceuticals
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Cipher Pharmaceutical Inc.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Daiichi Sankyo
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Johnson?Johnson
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Lupin Limited
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Pfizer
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Sun Pharmaceuticals
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Teva Pharmaceutical Industries Ltd.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Opioid Drug
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
